Cash & equivalents decreased 29.3%
Cash & equivalents changed -29.3% from the comparable as-filed period.
$101.7M→$71.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MED financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit decreased 30.3%
Gross profit changed -30.3% from the comparable as-filed period.
$76.6M→$53.4M3 prior comparisons
Inventory decreased 29.9%
Inventory changed -29.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$30.2M→$21.2M4 prior comparisons
Net income decreased 225.0%
Net income changed -225.0% from the comparable as-filed period.
$2.5M→-$3.1M2 prior comparisons
Operating income decreased 305.9%
Operating income changed -305.9% from the comparable as-filed period.
-$1.1M→-$4.3M3 prior comparisons
Operating margin moved 465 bp lower
Operating margin changed -465 basis points from the comparable as-filed period.
-1.01%→-5.66%3 prior comparisons
Revenue decreased 27.6%
Revenue changed -27.6% from the comparable as-filed period.
$105.6M→$76.4M3 prior comparisons
Selling, general & administrative decreased 25.7%
Selling, general & administrative changed -25.7% from the comparable as-filed period.
$77.7M→$57.7M3 prior comparisons
Stock-based compensation decreased 30.8%
Stock-based compensation changed -30.8% from the comparable as-filed period.
$2.6M→$1.8M3 prior comparisons
Gross margin moved 271 bp lower
Gross margin changed -271 basis points from the comparable as-filed period.
72.61%→69.90%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.